Evidence map›Paper›PMID 35263038›Full record

ArticleCurrent protocols2022

Preparation and Use of Cellular Reagents: A Low-resource Molecular Biology Reagent Platform.

Sanchita Bhadra, Inyup Paik, Jose-Angel Torres, Stéphane Fadanka, Chiara Gandini, Harry Akligoh, Jenny Molloy, Andrew D Ellington

Open access · greenAbstract read
In one paragraph

Article in Current protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Sanchita BhadraDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas.
Inyup PaikDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas.
Jose-Angel TorresFreshman Research Initiative, DIY Diagnostics Stream, The University of Texas at Austin, Austin, Texas.
Stéphane FadankaMboalab Biotech, Yaoundé, Cameroon.
Chiara GandiniDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Harry AkligohHive Biolab, Kentinkrono, Kumasi, Ghana.
Jenny MolloyDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Andrew D EllingtonDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas.
The University of Texas at Austin · USKumasi Technical University · GHNuclera (United Kingdom) · GBThe University of Texas Health Science Center at Houston · USUniversity of Cambridge · GB

Funding

Directed evolution of polymerases that can read and write extremely long sequencesR01EB027202 · NIBIB · UNIVERSITY OF TEXAS AT AUSTIN · PI ELLINGTON, ANDREW D · 2020 to 2024
$1.6M
Bill and Melinda Gates Foundation OPP1182120NIBIB NIH HHS R01 EB027202NIH HHS 1-R01-EB027202-01A1Welch Foundation F-1654
6 · The paper itself

Abstract

Protein reagents are indispensable for most molecular and synthetic biology procedures. Most conventional protocols rely on highly purified protein reagents that require considerable expertise, time, and infrastructure to produce. In consequence, most proteins are acquired from commercial sources, reagent expense is often high, and accessibility may be hampered by shipping delays, customs barriers, geopolitical constraints, and the need for a constant cold chain. Such limitations to the widespread availability of protein reagents, in turn, limit the expansion and adoption of molecular biology methods in research, education, and technology development and application. Here, we describe protocols for producing a low-resource and locally sustainable reagent delivery system, termed "cellular reagents," in which bacteria engineered to overexpress proteins of interest are dried and can then be used directly as reagent packets in numerous molecular biology reactions, without the need for protein purification or a constant cold chain. As an example of their application, we describe the execution of polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP) using cellular reagents, detailing how to replace pure protein reagents with optimal amounts of rehydrated cellular reagents. We additionally describe a do-it-yourself fluorescence visualization device for using these cellular reagents in common molecular biology applications. The methods presented in this article can be used for low-cost, on-site production of commonly used molecular biology reagents (including DNA and RNA polymerases, reverse transcriptases, and ligases) with minimal instrumentation and expertise, and without the need for protein purification. Consequently, these methods should generally make molecular biology reagents more affordable and accessible. © 2022 Wiley Periodicals LLC. Basic Protocol 1: Preparation of cellular reagents Alternate Protocol 1: Preparation of lyophilized cellular reagents Alternate Protocol 2: Evaluation of bacterial culture growth via comparison to McFarland turbidity standards Support Protocol 1: SDS-PAGE for protein expression analysis of cellular reagents Basic Protocol 2: Using Taq DNA polymerase cellular reagents for PCR Basic Protocol 3: Using Br512 DNA polymerase cellular reagents for loop-mediated isothermal amplification (LAMP) Support Protocol 2: Building a fluorescence visualization device.

Indexed as

DNAMolecular BiologyIndicators and ReagentsPolymerase Chain ReactionSynthetic BiologyDNAIndicators and Reagentscellular reagentsDIY equipmentdried bacterialocal production of molecular reagentslow-cost molecular biology reagentsnucleic acid amplification reagents

Identifiers

PMID35263038
PMCPMC9094432
OpenAlexW4220730410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.